Atom-economic and regioselective Csp3 -Csp3 bond formation has been achieved by rapid C-H alkylation of unprotected secondary arylamines with unactivated alkenes. The combination of Ta(CH SiMe ) Cl , and a ureate N,O-chelating-ligand salt gives catalytic systems prepared in situ that can realize high yields of β-alkylated aniline derivatives from either terminal or internal alkene substrates. These new catalyst systems realize C-H alkylation in as little as one hour and for the first time a 1:1 stoichiometry of alkene and amine substrates results in high yielding syntheses of isolated amine products by simple filtration and concentration.
The efficient and catalytic amination
of unactivated alkenes with
simple secondary alkyl amines is preferentially achieved. A sterically
accessible, N,O-chelated cyclic
ureate tantalum catalyst was prepared and characterized by X-ray crystallography.
This optimized catalyst can be used for the hydroaminoalkylation of
1-octene with a variety of aryl and alkyl amines, but notably enhanced
catalytic activity can be realized with challenging N-alkyl secondary amine substrates. This catalyst offers turnover
frequencies of up to 60 h–1, affording full conversion
at 5 mol% catalyst loading in approximately 20 min with these nucleophilic
amines. Mechanistic investigations, including kinetic isotope effect
(KIE) studies, reveal that catalytic turnover is limited by protonolysis
of the intermediate 5-membered azametallacycle. A Hammett kinetic
analysis shows that catalytic turnover is promoted by electron rich
amine substrates that enable catalytic turnover. This more active
catalyst is shown to be effective for late stage drug modification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.